The following speakers have confirmed their participation:

Associate Professor of Biochemistry and Molecular Biology at Complutense University (Madrid, Spain). She began her scientific career in 1995, joining Dr. Manuel Guzmán´s group, where she described the antitumor properties of cannabinoids, and their mechanism of action. After a 3-year postdoctoral stay in Dr. Daniele Piomelli´s laboratory (University of California, Irvine), Cristina returned to Spain in 2003, and started coordinating new lines of research within Dr. Guzmán´s group, focused on breast cancer, and potential cannabinoid receptors other than CB1 and CB2. Cristina was the Secretary of the Spanish Cannabinoid Research Society, and is currently a member of its Board of Directors, and is one of the founders and current Secretary of the recently created Spanish Observatory of Medical Cannabis.
Professor of Neurology and Director of the UAB Epilepsy Center. After finishing medical school in Poland (Uniwersytet Mikolaja Kopernika w Toruniu / Akademia Medyczna w Bydgoszczy) and Germany (Universität des Saarlandes, Medizinisches Facultät in Homburg, Saar) he worked in the laboratory of Dr. Faye Silverstein at the University of Michigan where he examined molecular responses to ischemic and NMDA-mediated brain injury. In 1997 he received PhD in neuroembryology from his Alma Mater in Poland (Uniwersytet Mikolaja Kopernika w Toruniu / Akademia Medyczna w Bydgoszczy). After completing neurology and epilepsy training at the University of Cincinnati in Cincinnati, Ohio, he trained in functional MRI with Dr. Jeff Binder at the Medical College of Wisconsin in Milwaukee, Wisconsin. Later, as part of K23 training, he spent time in the laboratory of Dr. Jean Gotman at Montreal Neurological Institute in Montreal, Canada learning EEG/fMRI methods. For over 20 years he has been examining the effects of acute, subacute and chronic brain injury (e.g., stroke or epilepsy) on brain plasticity using MRI, fMRI, DTI and EEG/fMRI. One of his long-term goals is to develop fMRI as a diagnostic tool for various neurological conditions including epilepsy and as a biomarker for treatment response. More recently, he has been examining the effects of cannabidiol on seizures and epilepsy using clinical and neuroimaging tools. He is the co-editor with Dr. Orrin Devinsky of the recently published special issue of Epilepsy & Behavior titled “Cannabinoids and Epilepsy.” He is an author or co-author of almost 200 scientific articles and more than 300 presentations at scientific conferences.
Graduated in law and in sociology from the Jagiellonian University in Cracow. Received scholarships from the University of Connecticut, the Cambridge Colleges Hospitality Scheme for Central and Eastern European Scholars, the Alexander von Humboldt Foundation and Max Planck Society.
Head of the Department of Criminology at the Faculty of Law and Administration of the Jagiellonian University. In the years 2002 – 2008 president of the Polish Society of Criminology. In 2006 – 2009 the President of the European Society of Criminology. Since 2008 member of the Scientific Committee of the European Monitoring Center for Drugs and Drug Addiction in Lisbon. Cooperates with the (Polish) National Bureau for Drug Prevention.
Prof. Krajewski is the author of numerous scientific papers on criminological and legal issues of drug addiction and drug policy, including the monograph titled "Sense and senselessness of prohibition. Criminal law against drugs and drug addiction" (Cracow 2002).
Mara Gordon specializes in the development of cannabis treatment protocols for seriously ill patients in California. She is the co-founder of Aunt Zelda’s, Calla Spring Wellness, and Zelda Therapeutics. Mara has presented at numerous medical conferences around the globe.

Aunt Zelda’s is a pioneering, data-driven developer of cannabis-based plant medicines. Their products are the result of years of research and development in consultation with knowledgeable physicians and world-renowned researchers. Utilizing time-proven extraction process improved with modern technology, Aunt Zelda’s offers organic medicines of precisely measured potency and purity that empower patients to dose to the milligram and unlock the therapeutic potential of cannabis.

Calla Spring Wellness is a telemedicine platform utilized by physicians and nurses, expert in the endocannabinoid system, to guide patients in the best use of cannabinoid-based medicines while integrating with their standard treatments.

Zelda Therapeutics brings together some of the world’s leading researchers and clinicians active in the study and use of medicinal cannabis to treat a variety of ailments. Presently, Zelda is engaged in pre-clinical research in multiple forms of cancer, and clinical research in insomnia, eczema, epilepsy, and more.

Prior to Aunt Zelda’s, Mara worked as a process engineer, helping Fortune 500 companies create intelligent software utilizing the Rational Unified Process. This experience has enabled her to take a detailed and scientific approach to medical cannabis. Her expertise is now utilized through board positions with CannPal, Fundacion Daya, National Association of Cannabis Businesses (NACB), Patients Out of Time, and Gabriella’s Kitchen.
Medical doctor, chest surgeon from the Lower Silesian Center for Lung Diseases in Wroclaw and general surgeon of the 1st degree. Has over 30 years of clinical experience in the treatment of lung cancer.
For almost two years associated with the medical use of cannabis in cancer. In his everyday practice he treats mainly oncological patients struggling with lung cancer, but every cancer patient will find his support.
Specialist in pediatric neurology, for more than 20 years has been working with children diagnosed with drug-resistant epilepsy. In his work he uses innovative methods of diagnosis and treatment.
In 2000, together with radiologist Dr. Andrzej Piotrowski, he described the first use in Poland of single photon emission tomography (SPECT) during an epileptic seizure. This study is still of importance in cases of difficult-to-diagnose epilepsy.
Since 2002 he's been developing a highly specialized therapy with ketogenic diet. Currently in Poland the largest group of children treated with this method is under Dr. Bachanski's care.
In 2014 he officially introduced treatment with cannabinoids of children with refractory epilepsy.
Born in Zabrze (Poland), his family emigrated to Israel when he was 10 years old. He speaks Polish and still asks about Górnik Zabrze (one of the most famous Polish football club). His father was a physician in Poland, in Katowice and so were his grandfathers. He followed the family tradition and studied medicine at Tel Aviv University (Dr. Dor specializes in family medicine). Also a graduate of Harvard University's Kennedy School of Government – he holds a master's degree in public administration.
For many years has been associated with the Israeli Ministry of Health, among other positions as Head of Community Medicine Division and Deputy Director of Health Management Services.

In 2014 he received the Presidential Award for his volunteer work dedicated to establishing and directing a clinic for uninsured illegal immigrants, refugees and victims of human trafficking. The personal doctor of two Popes during their visits to Israel.
At present he acts as a Senior Medical Advisor for the Ministry of Health's Medical Cannabis Unit. Lectures, in Israel and outside, about medicinal use of cannabis. At the Ariel University (where he's been teaching health management at the Faculty of Health Sciences) he established the first academic cannabis course recognized by the Israeli Council for Higher Education.

He is an active family physician in Jerusalem.
Master of Pharmacy, professionally active - works in a pharmacy in Konin. Co-founder of the Medical Marijuana Treatment Point in Konin - the first in Poland information point for patients interested in medical marijuana, financed from the city budget.
Piotr Liroy-Marzec – Polish rapper, music producer, businessman and politician. Member of the pop music section at the ZPAV Phonographic Academy, member of the Polish parliament VIII term. In 2015 he has submitted a bill regulating the use of medical marijuana to the parliament.
Mr. Jot is the author of books: „Marijuana cures” (Marihuana leczy) and „Truth about marijuana” (Odkłamywanie marihuany). Propagator of the knowledge regarding medical properties of marijuana. He is a supporter of the theory that the most harmful aspect of marijuana is its prohibition. He bases his conviction on scientific research. He believes that rational approach to marijuana is also possible in Poland. .
Graduated from University of South Bohemia in České Budějovice, the Faculty of Agriculture. Her thesis was on cultivation and use of hemp in the Czech Republic.
Since 2000 she has been a member of Konopa, a Czech NGO whose purpose is to provide education about the benefits of hemp.

She is the founder (2010) and CEO of Hempoint Ltd., a company dedicated to cultivation of organic hemp and to production of a big variety of hemp-derived food products, including oil, ready-to-eat roasted seeds, cookies, tea, chocolate with hemp flowers or hemp seed butter. Hempoint also advises Czech farmers on hemp cultivation and supplies them with certified seeds. The company is also active in the field of hemp processing research and international drug policy.

In 2010 she became a member of the Committee on Petitions for medical cannabis use in Czechia. In 2013 was one of the founders of KOPAC – association of Czech cannabis patients. Since 2014 she is working for Prague-based International Cannabis and Cannabinoids Institute (ICCI) on project called Patient Focused Certification which provides standards and guidelines for safe production of cannabis products.
Prof. Aharon (Ari) Eyal is a retired Professor of Applied Chemistry from the Hebrew University of Jerusalem; author of 80 peer-reviewed articles and book chapters; was involved in more than 300 industrial projects in about 70 firms worldwide, including multinational, multi-billion dollar companies (20 years with the agri-giant Cargill, >$100 Billion); inventor of more than 200 patent families and patent applications; founded several startup companies.
Chemist, founder of the Polish laboratory specializing in analyzing the composition of hemp products.

Mother of Max, the first Polish patient legally treated with cannabis-based preparations. Fighting for the possibility of treating her own son, she became an activist and the face of the struggle for the legalization of cannabis for medical purposes. Experienced in the field of medical use of cannabinoids, she is an initiator and organizer of numerous activities aimed at regulating the legal status of cannabis in Poland. She represents the Coalition for Medical Marijuana, which – through MP Piotr Liroy Marzec – submitted to the Polish parliament a draft amendment to the existing law.
Since 2011 she runs the "Step by Step" foundation in the town of Olawa, which deals with therapy and support for people with intellectual disabilities and their families.
A graduate of the University of Gdansk Faculty of Law and Administration, PhD student at the Institute of Law Studies of the Polish Academy of Sciences. Research interests: theory of evidence law, medical law and regulation of the pharmaceutical market, administrative proceedings.
Professionally associated with the Bioinfobank Institute in Poznan. Since 2012 he has been managing research projects in the field of public health and regulation of scientific research.
Since 2010 has been an active participant in legislative work, public consultations and court proceedings regarding marijuana in Poland. The chief consultant of the Coalition for Medical Marijuana in the field of legal sciences and legislation.
Dorota Schewe (drug-resistant epilepsy)
Paulina Janowicz (drug-resistant epilepsy)
Hubert Bartol (brain tumor)
Anna Kalita (brain tumor)
This website uses cookies to allow the registration of event participants and service related processes. By using this site you agree on use of cookies, according to the current browser settings.
Accept